Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of DNA vaccine EP-1233 and recombinant MVA-HIV polytope vaccine MVA-mBN32, separately and in a combined prime-boost regimen, when given to healthy, vaccinia-naive, HIV-1-uninfected adults
Description
HVTN 067 is a Phase I clinical trial to evaluate the safety and immunogenicity of DNA vaccine EP-1233 and recombinant MVA-HIV polytope vaccine MVA-mBN32, alone and as a prime-boost.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.